Eyeworld

19 Supported by educational grants from EyePoint Pharmaceuticals, ImprimisRx, Ocular Therapeutix, and Omeros. Additional grants pending. Registration is available onsite! Preliminary Program 5:30 pm Welcome and Introduction – Eric D. Donnenfeld, MD 5:40 pm The Impact of Pain and Inflammation: Who is at Risk, Who is Nonadherent, and Why It Matters – Edward J. Holland, MD 5:50 pm Current and Emerging Approaches to Minimize Topical Drops Intracameral Dexamethasone – Eric D. Donnenfeld, MD Punctal Plug Dexamethasone – Alice T. Epitropoulos, MD Nanotechnology Loteprednol – Edward J. Holland, MD Intracameral Ketorolac/Phenylephrine – Denise M. Visco, MD, MBA Compounded Medications – William F. Wiley, MD 6:15 pm Panel Discussion: Evolving Reimbursement Models, Pass-Through, and Their Impact on Access to New Technology to Control Pain and Inflammation 6:25 pm Concluding Remarks – Edward J. Holland, MD Designation Statement The American Society of Cataract and Refractive Surgery designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™. Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits. Notice of Off-Label Use Presentations This program may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to de- termine the FDA clearance status of each drug or device he/she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented. ADA/Special Accommodations ASCRS fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also requires ADA compliance from its contracted vendors and facilities. Any participant in this educational program who requires special accommodations or services should contact an ASCRS or EyeWorld staff member onsite

• Cover